ACE2 and COVID-19: Recent studies have reported that compared to normal individuals, COVID-19 patients have altered gut microbiota composition and dysbiosis, which in turn can influence COVID-19 disease course and severity through gut barrier dysfunction, altered ACE2 expression, and influencing the gut–lung axis [6].